A randomized trial of the effectiveness of topical "aBH Gel" (Ativan®, Benadryl®, Haldol®) vs. Placebo in cancer patients with nausea

Journal of Pain and Symptom Management

Volumn 48, Issue 5, 2014, Pages 797-803

  Fletcher, Devon S ^a   Coyne, Patrick J ^a   Dodson, Patricia W ^a   Parker, Gwendolyn G ^a   Wan, Wen ^a   Smith, Thomas J ^b  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

cancer; gels; Nausea; topical antiemetics; vomiting

Indexed keywords

ANALGESIC AGENT; DIPHENHYDRAMINE; DIPHENHYDRAMINE PLUS HALOPERIDOL PLUS LORAZEPAM; HALOPERIDOL; LORAZEPAM; PLACEBO; TOPICAL AGENT; UNCLASSIFIED DRUG; ANTIEMETIC AGENT; DRUG COMBINATION; GEL;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CANCER PATIENT; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DROWSINESS; DRUG EFFICACY; FEMALE; GEL; HUMAN; MALE; MEMORIAL SYMPTOM ASSESSMENT SCALE CONDENSED; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NAUSEA; OUTCOME ASSESSMENT; PLACEBO EFFECT; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SYMPTOM ASSESSMENT; TOPICAL TREATMENT; VOMITING; ADMINISTRATION AND DOSAGE; ADOLESCENT; ADVERSE EFFECTS; DRUG COMBINATION; MIDDLE AGED; NEOPLASM; PATHOPHYSIOLOGY; TOPICAL DRUG ADMINISTRATION; TREATMENT OUTCOME; YOUNG ADULT;

ADMINISTRATION, TOPICAL; ADOLESCENT; ADULT; AGED; ANTIEMETICS; CROSS-OVER STUDIES; DIPHENHYDRAMINE; DOUBLE-BLIND METHOD; DRUG COMBINATIONS; FEMALE; GELS; HALOPERIDOL; HUMANS; LORAZEPAM; MALE; MIDDLE AGED; NAUSEA; NEOPLASMS; TREATMENT OUTCOME; VOMITING; YOUNG ADULT;

EID: 84911443073     PISSN: 08853924     EISSN: 18736513     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2014.02.010     Document Type: Article

References (27)

1. N. Dhillon, S. Kopetz, and B.L. Pei Clinical findings of a palliative care consultation team at a comprehensive cancer center J Palliat Med 11 2008 191 197
2. J.A. Paice, J.H. Von Roenn, and J.C. Hudgins Morphine bioavailability from a topical gel formulation in patients J Pain Symptom Manage 35 2008 314 320
3. N.J. Meropol, and K.A. Schulman Cost of cancer care: issues and implications J Clin Oncol 25 2007 180 186
4. D.R. Hoover, S. Crystal, R. Kumar, U. Sambamoorthi, and J.C. Cantor Medical expenditures during the last year of life: findings from the 1992-1996 Medicare current beneficiary survey Health Serv Res 37 2002 1625 1642
5. G.F. Riley, and J.D. Lubitz Long-term trends in Medicare payments in the last year of life Health Serv Res 45 2010 565 576
6. D.E. Campbell, J. Lynn, T.A. Louis, and L.R. Shugarman Medicare program expenditures associated with hospice use Ann Intern Med 140 2004 269 277
7. R. Brumley, S. Enguidanos, and P. Jamison Increased satisfaction with care and lower costs: results of a randomized trial of in-home palliative care J Am Geriatr Soc 55 2007 993 1000
8. D.J. Weschules Tolerability of the compound ABHR in hospice patients J Palliat Med 8 2005 1135 1143
9. R.B. Moon ABHR gel in the treatment of nausea and vomiting in the hospice patient Int J Pharm Compd 10 2006 95 98
10. Fields SW. Meeting the needs of the hospice patient. Pharmacy Times, June 2007. Available from http://www.pharmacytimes.com/publications/issue/2007/2007-06/2007-06-6591. Accessed May 28, 2014.
11. J. Bleicher, A. Bhaskara, and T. Huyck Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials J Support Oncol 6 2008 27 32
12. M.K. Buss, and R.M. Arnold Challenges in palliative care research: one experience J Palliat Med 7 2004 405 407
13. T.J. Smith, J. Ritter, and J. Polkis "ABH gel" (Ativan®, lorazepam; Benadryl®, diphenhydramine; haloperidol, Haldol®, gel) is not absorbed from the skin of normal volunteers J Pain Symptom Manage 43 2012 961 966
14. R. Regenthal, M. Krueger, C. Koeppel, and R. Preiss Drug levels: therapeutic and toxic serum/plasma concentrations of common drugs J Clin Monit Comput 15 1999 529 544
15. P. Perkins, and S. Dorman Haloperidol for the treatment of nausea and vomiting in palliative care patients Cochrane Database Syst Rev 2 2009 CD006271
16. J. Vella-Brincat, and A.D. Macleod Haloperidol in palliative care Palliat Med 18 2004 195 201
17. D.J. Greenblatt Clinical pharmacokinetics of oxazepam and lorazepam Clin Pharmacokinet 6 1981 89 105
18. V.T. Chang, S.S. Hwang, B. Kasimis, and H.T. Thaler Shorter symptom assessment instruments: the Condensed Memorial Symptom Assessment Scale (CMSAS) Cancer Invest 22 2004 526 536
19. S. Murdan A review of pluronic lecithin organogel as a topical and transdermal drug delivery system Hosp Pharmacist 12 2005 267 270
20. D.D. Price, D.G. Finniss, and F. Benedetti A comprehensive review of the placebo effect: recent advances and current thought Annu Rev Psychol 59 2008 565 590
21. P. Glare, G. Pereira, L.J. Kristjanson, M. Stockler, and M. Tattersall Systematic review of the efficacy of antiemetics in the treatment of nausea in patients with far-advanced cancer Support Care Cancer 12 2004 432 440
22. V. Prasad, A. Cifu, and J.P. Ioannidis Reversals of established medical practices: evidence to abandon ship JAMA 307 2012 37 38
23. P. Glare, J. Miller, T. Nikolova, and R. Tickoo Treating nausea and vomiting in palliative care: a review Clin Interv Aging 6 2011 243 259
24. P.J. Coyne, L.A. Hansen, and A.C. Watson Compounded drugs. Are customized prescription drugs a salvation, snake oil, or both? Am J Nurs 103 2003 78 79 81, 84-85
25. J.K. Glisson, R.L. Wood, P.B. Kyle, and J.D. Clearly Bioavailability of promethazine in a topical pluronic organogel: a pilot study Int J Pharm Compd 9 2005 242 246
26. J. Lee, M. Dodd, S. Dibble, and D. Abrams Review of acupressure studies for chemotherapy-induced nausea and vomiting control J Pain Symptom Manage 36 2008 529 544
27. A. Lee, and L.T. Fan Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting Cochrane Database Syst Rev 2 2009 CD003281